Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

NVTA

Invitae (NVTA)

Invitae Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:NVTA
DateTimeSourceHeadlineSymbolCompany
02/10/20217:30AMPR Newswire (US)Invitae to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceNYSE:NVTAInvitae Corporation
02/09/20219:07PMDow Jones NewsSoftBank to Make $900 Million Investment in Pacific BiosciencesNYSE:NVTAInvitae Corporation
02/05/20217:53AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:NVTAInvitae Corporation
02/05/20216:13AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NVTAInvitae Corporation
02/03/20215:27PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
02/03/20217:30AMPR Newswire (US)Invitae to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021NYSE:NVTAInvitae Corporation
01/26/20214:13PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
01/26/20214:05PMPR Newswire (US)Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock and Closing of Under...NYSE:NVTAInvitae Corporation
01/21/20218:37PMPR Newswire (US)Invitae Announces Pricing of Public Offering of Common StockNYSE:NVTAInvitae Corporation
01/20/20214:25PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:NVTAInvitae Corporation
01/20/20214:05PMPR Newswire (US)Invitae Announces Proposed Public Offering of Common StockNYSE:NVTAInvitae Corporation
01/14/20217:30AMPR Newswire (US)Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) i...NYSE:NVTAInvitae Corporation
01/13/20218:02AMGlobeNewswire Inc.Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing PlatformNYSE:NVTAInvitae Corporation
01/11/20217:30AMPR Newswire (US)Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Vol...NYSE:NVTAInvitae Corporation
01/08/20215:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
12/29/20207:30AMPR Newswire (US)Invitae to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNYSE:NVTAInvitae Corporation
12/23/20205:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
12/23/20205:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
12/17/20207:30AMPR Newswire (US)Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses FasterNYSE:NVTAInvitae Corporation
12/09/20207:30AMPR Newswire (US)Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer S...NYSE:NVTAInvitae Corporation
12/01/20209:56AMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NYSE:NVTAInvitae Corporation
12/01/20209:55AMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NYSE:NVTAInvitae Corporation
11/27/20205:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
11/23/20206:02AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
11/23/20206:01AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:NVTAInvitae Corporation
11/19/202010:57AMPR Newswire (Canada)New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer PatientsNYSE:NVTAInvitae Corporation
11/19/202010:57AMPR Newswire (US)New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer PatientsNYSE:NVTAInvitae Corporation
11/10/20202:53PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NVTAInvitae Corporation
11/09/20204:25PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:NVTAInvitae Corporation
11/09/20204:03PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
 Showing the most relevant articles for your search:NYSE:NVTA